Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Galmed Pharmaceuticals Ltd. (GLMD)

« Back to company index

GLMD Chatter Timeline

Stock Ticker for GLMD

Most Active Tweeters for GLMD

UserTweets
@thefinreviewer 6
@bibeypost_stock 4
@bulletin_en 4
@BlogYomi 3
@whatsonthorold2 3

Recent Tweets for GLMD

BlogYomi @BlogYomi
United Therapeutics Corporation $GLMD Comparison side by side https://t.co/kZm57MS9TJ
April 18th 2019, 10:04pm
bibeypost_stock @bibeypost_stock
Are Analysts Bullish Galmed Pharmaceuticals Ltd. $GLMD After Last Week? https://t.co/7Afa3iaXIF
April 18th 2019, 4:04pm
SwingTradeBot @SwingTradeBot
50 DMA Resistance today: $GLMD ... https://t.co/mnYaiRq1wk
April 18th 2019, 3:04pm
thefinreviewer @thefinreviewer
Galmed Pharmaceuticals LTD $GLMD Valuation Declined While Bvf Raised Stake; High Pointe Capital Management Continue… https://t.co/EkMu89K9Jb
April 18th 2019, 9:04am
JonathanWexler3 @JonathanWexler3
$GLMD Sense of Urgency? Check. Highly safe? Check. Global trials? Not sure those are cheaper. Definitely less re… https://t.co/yVoWCTMYQ1
April 17th 2019, 1:04pm
UlmHi @UlmHi
Galmed P $GLMD Valuation Declined While Ubs Oconnor Has Trimmed Its Stake; As Aspen Insurance Holdings LTD $AHL Sto… https://t.co/LzVDAbHEnK
April 17th 2019, 11:04am
BlogYomi @BlogYomi
Pacific Biosciences of California Inc. $GLMD https://t.co/V2Jqm0QQDC
April 17th 2019, 12:04am
thefinreviewer @thefinreviewer
Comparing of Cyanotech Corporation $GLMD https://t.co/hJjH4Kw0rc
April 14th 2019, 8:04pm
bulletin_en @bulletin_en
Reviewing Mesoblast Limited $GLMD's results https://t.co/uqXRmsmpZf
April 14th 2019, 4:04pm
mmahotstuff1 @mmahotstuff1
BidaskScore Decides to Downgrade Galmed Pharmaceuticals $GLMD. Will Other Analysts Follow? https://t.co/x3PKbaHGam
April 14th 2019, 12:04am
whatsonthorold2 @whatsonthorold2
Galmed Pharmaceuticals $GLMD Seems to Be a Stock That BidaskScore Is a Bit Wary of; Firm Downgrades Shares https://t.co/wLg9rrgEeO
April 14th 2019, 12:04am
bibeypost_stock @bibeypost_stock
Analysts at BidaskScore Give Galmed Pharmaceuticals $GLMD a Downgrade https://t.co/NmBUvXRCKh
April 14th 2019, 12:04am
reurope_stock @reurope_stock
Galmed Pharmaceuticals $GLMD Receives a Lower Rating From BidaskScore. Is it Time to Sell Shares? https://t.co/lPfdnhz1s6
April 14th 2019, 12:04am
thefinreviewer @thefinreviewer
Reviewing Achillion Pharmaceuticals Inc. $GLMD's results https://t.co/uo2I4QEwQU
April 13th 2019, 9:04pm
UlmHi @UlmHi
As Galmed Pharmaceuticals LTD $GLMD Stock Value Declined, Bvf Has Upped Its Stake; Bank Of New York Mellon Has Uppe… https://t.co/xHw0GZolG1
April 11th 2019, 8:04am
bulletin_en @bulletin_en
Comparing of Synlogic Inc. $GLMD https://t.co/g2lxiQHLa6
April 11th 2019, 3:04am
thefinreviewer @thefinreviewer
Reviewing Nektar Therapeutics $GLMD's results https://t.co/m72XNkFDf0
April 10th 2019, 9:04pm
ChartMill @ChartMill
$GLMD has only a medium technical rating, but it does show a decent setup pattern. https://t.co/IXEQ73mWvS https://t.co/gOhKqBdDwt
April 10th 2019, 8:04pm
BlogYomi @BlogYomi
Contrasting of Pieris Pharmaceuticals Inc. $GLMD https://t.co/VAHVevkDZQ
April 10th 2019, 1:04pm
Miljenkoz @Miljenkoz
$GLMD https://t.co/uq60pK6v16 General agreement has been reached with FDA on key aspects of the ARMOR study includ… https://t.co/lMnChmCPSi
April 9th 2019, 4:04pm
StockNewsNow @StockNewsNow
$GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start… https://t.co/qPkuetwtJX
April 9th 2019, 11:04am
Stock_News_Now @Stock_News_Now
$GLMD: New SEC Filing for GLMD: Form 6-K (No. 0001144204-19-018741): https://t.co/J8Bf87NEwb
April 9th 2019, 9:04am
tradnews_ @tradnews_
RT @OpenOutcrier: $GLMD (+7.1% pre) Galmed Pharma Reports Complete End of Phase 2 Meeting with FDA and Plan for Start of Phase 3 https://t…
April 9th 2019, 8:04am
OpenOutcrier @OpenOutcrier
$GLMD (+7.1% pre) Galmed Pharma Reports Complete End of Phase 2 Meeting with FDA and Plan for Start of Phase 3 https://t.co/ujrSuWv7kR
April 9th 2019, 8:04am
okim59 @okim59
Galmed readies pivotal study of NASH candidate Aramchol $GLMD https://t.co/f0us9UYF2c
April 9th 2019, 8:04am
newswithvalue @newswithvalue
$GLMD: Galmed readies pivotal study of NASH candidate Aramchol: https://t.co/kbUkHueN44
April 9th 2019, 8:04am
StockTexts @StockTexts
$GLMD Galmed Pharmaceuticals Ltd. SEC Filing: Form 6-K https://t.co/j85vGROo9o
April 9th 2019, 8:04am
confcalltran @confcalltran
Galmed Pharmaceuticals Announces Successful Completion Of https://t.co/91x72e7kSg $GLMD
April 9th 2019, 8:04am
MarketCurrents @MarketCurrents
$GLMD - Galmed readies pivotal study of NASH candidate Aramchol https://t.co/YaOvUhALDn
April 9th 2019, 8:04am
Hall8Jack @Hall8Jack
RT @BioStocks: $GLMD Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 https://t.co/PJFzOISq…
April 9th 2019, 7:04am
biostockinfo @biostockinfo
RT @TraderTexMex: $GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Pha…
April 9th 2019, 7:04am
newswithvalue @newswithvalue
$GLMD: Galmed Pharmaceuticals Announces Successful Completion of End …: https://t.co/bfRaMCVLnp
April 9th 2019, 7:04am
bthefirsttoknow @bthefirsttoknow
$GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start… https://t.co/MQ9NuU8cQb
April 9th 2019, 7:04am
RSIDayTrader @RSIDayTrader
good thing $GLMD didn't fail or have setbacks w this end of ph2 mtg with FDA.. helpful PR
April 9th 2019, 7:04am
TraderTexMex @TraderTexMex
$GLMD Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3
April 9th 2019, 7:04am
BioStocks @BioStocks
$GLMD Announces Successful Completion of End of Phase 2 Meeting With FDA and Plan for Start of Phase 3 https://t.co/PJFzOISqVi
April 9th 2019, 7:04am
thefinreviewer @thefinreviewer
Seres Therapeutics Inc. $GLMD Comparing side by side https://t.co/zhnZw10PUu
April 9th 2019, 1:04am
whatsonthorold2 @whatsonthorold2
This is what analysts have to say about Galmed Pharmaceuticals Ltd. $GLMD after last week. https://t.co/tTnSjvvnRb
April 8th 2019, 2:04pm
bibeypost_stock @bibeypost_stock
Are Analysts Bullish Galmed Pharmaceuticals Ltd. $GLMD After Last Week? https://t.co/Z24aoQ2zH0
April 8th 2019, 2:04pm
reurope_stock @reurope_stock
Analysts are on the Bearish side about Galmed Pharmaceuticals Ltd. $GLMD this week. https://t.co/xrCc3hqxkb
April 8th 2019, 2:04pm
bulletin_en @bulletin_en
Weekly Galmed Pharmaceuticals Ltd. $GLMD Ratings as of Apr 8, 2019 https://t.co/V3fMo4Ufmo
April 8th 2019, 1:04pm
whatsonthorold2 @whatsonthorold2
It Seems Galmed Pharmaceuticals LTD. - Ordinary Shares $GLMD Will Go Down. Just Reported More Shorted Shares https://t.co/P3f4daf8Vc
April 8th 2019, 11:04am
bibeypost_stock @bibeypost_stock
After Reaching Milestone, Is Galmed Pharmaceuticals LTD. - Ordinary Shares $GLMD’s Short Interest Revealing Somethi… https://t.co/1POi4xjEZh
April 8th 2019, 11:04am
bulletin_en @bulletin_en
LogicBio Therapeutics Inc. $GLMD Comparing side by side https://t.co/A5F44f44Sr
April 8th 2019, 12:04am
dakotafinancial @dakotafinancial
Galmed Pharmaceuticals Ltd $GLMD Receives $36.86 Consensus PT from Brokerages https://t.co/yvgPcLhaV3
April 6th 2019, 11:04pm
macondailynews @macondailynews
Galmed Pharmaceuticals Ltd $GLMD Receives Average Rating of “Buy” from Brokerages https://t.co/4KQbcQ1SUV
April 6th 2019, 11:04pm
thefinreviewer @thefinreviewer
Reviewing Auris Medical Holding AG $GLMD's results https://t.co/AgTLDgujuj
April 6th 2019, 9:04pm
macondailynews @macondailynews
Zacks: Brokerages Anticipate Galmed Pharmaceuticals Ltd $GLMD to Announce -$0.19 EPS https://t.co/YWFtPrnxWf
April 6th 2019, 9:04pm
TheMarketsDaily @TheMarketsDaily
Galmed Pharmaceuticals Ltd $GLMD Expected to Announce Earnings of -$0.19 Per Share https://t.co/u2PwCo6TFm
April 6th 2019, 9:04pm
WatchlistN @WatchlistN
Brokerages Expect Galmed Pharmaceuticals Ltd $GLMD Will Post Quarterly Sales of $230,000.00 https://t.co/UH5157gRkq
April 6th 2019, 9:04pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.